CytomX Therapeutics, Inc. — Form 4/A
Filed October 16, 2026 · analyzed by the Insider Agent
4/A
▼ Likely negative
significance 49/100
What the filing says
CEO McCarthy Sean A. (CTMX) sold 204K shares (~$462K) on the open market (37% of holdings). Large sale — ~37% of holdings.
Why this rating
Large sale — ~37% of holdings.
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.